Literature DB >> 22846789

Predictors of survival among pediatric and adult ependymoma cases: a study using Surveillance, Epidemiology, and End Results data from 1973 to 2007.

E Susan Amirian1, Terri S Armstrong, Kenneth D Aldape, Mark R Gilbert, Michael E Scheurer.   

Abstract

BACKGROUND: Despite previous research, prognostic factors for ependymoma remain relatively controversial. The purpose of our study was to examine demographic, clinical, and tumor attributes as potential predictors of survival using Surveillance, Epidemiology, and End Results (SEER) program data (1973-2007).
METHODS: All ependymoma (ICD-O-3 code 9391) and anaplastic ependymoma cases (ICD-O-3 code 9392) with complete data (n = 2,369 and n = 319, respectively) were included from SEER. Predictive Cox regression models were built separately among pediatric and adult cases. Recursive partitioning was used to corroborate results from regression models.
RESULTS: Among pediatric cases, tumor characteristics with a significantly increased mortality risk were anaplastic histology (vs. low grade, HR: 1.51, 95% CI: 1.04-2.19) and infratentorial tumor location (vs. spinal cord, HR: 3.86, 95% CI: 1.17-12.77). Among adults, supratentorial tumors were associated with higher mortality hazard (vs. spinal cord tumors) than infratentorial tumors (HR: 4.83, 95% CI: 3.49-6.68 and HR: 2.41, 95% CI: 1.79-3.25, respectively). Complete surgical resection of the tumor conferred the most protection among pediatric and adult patients.
CONCLUSION: Our results indicate that treatment type and tumor characteristics are important prognostic factors in patients with ependymoma. However, there may be key differences between pediatric and adult cases regarding how these factors influence survival.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22846789      PMCID: PMC3470871          DOI: 10.1159/000339320

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  17 in total

1.  Post-operative radiation improves survival in children younger than 3 years with intracranial ependymoma.

Authors:  Matthew Koshy; Shayna Rich; Thomas E Merchant; Usama Mahmood; William F Regine; Young Kwok
Journal:  J Neurooncol       Date:  2011-06-03       Impact factor: 4.130

Review 2.  Classification and regression tree analysis in public health: methodological review and comparison with logistic regression.

Authors:  Stephenie C Lemon; Jason Roy; Melissa A Clark; Peter D Friedmann; William Rakowski
Journal:  Ann Behav Med       Date:  2003-12

3.  Relative risk trees for censored survival data.

Authors:  M LeBlanc; J Crowley
Journal:  Biometrics       Date:  1992-06       Impact factor: 2.571

Review 4.  Ependymoma: results, prognostic factors and treatment recommendations.

Authors:  M P McLaughlin; R B Marcus; J M Buatti; W M McCollough; J P Mickle; A Kedar; B L Maria; R R Million
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-03-01       Impact factor: 7.038

5.  Treatment of intracranial ependymomas of children: review of a 15-year experience.

Authors:  P Rousseau; J L Habrand; D Sarrazin; C Kalifa; M J Terrier-Lacombe; C Rekacewicz; A Rey
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-01-15       Impact factor: 7.038

Review 6.  Ependymoma.

Authors:  Michele Reni; Gemma Gatta; Elena Mazza; Charles Vecht
Journal:  Crit Rev Oncol Hematol       Date:  2007-05-04       Impact factor: 6.312

7.  Multicentric French study on adult intracranial ependymomas: prognostic factors analysis and therapeutic considerations from a cohort of 152 patients.

Authors:  Philippe Metellus; Marylin Barrie; Dominique Figarella-Branger; Olivier Chinot; Roch Giorgi; Joanny Gouvernet; Anne Jouvet; Jacques Guyotat
Journal:  Brain       Date:  2007-04-19       Impact factor: 13.501

8.  The histologic grade is a main prognostic factor for patients with intracranial ependymomas treated in the microneurosurgical era: an analysis of 258 patients.

Authors:  Andrey Korshunov; Andrey Golanov; Regina Sycheva; Valery Timirgaz
Journal:  Cancer       Date:  2004-03-15       Impact factor: 6.860

9.  Incidence patterns for ependymoma: a surveillance, epidemiology, and end results study.

Authors:  Courtney S McGuire; Kristin L Sainani; Paul G Fisher
Journal:  J Neurosurg       Date:  2009-04       Impact factor: 5.115

10.  Both location and age predict survival in ependymoma: a SEER study.

Authors:  Courtney S McGuire; Kristin L Sainani; Paul Graham Fisher
Journal:  Pediatr Blood Cancer       Date:  2009-01       Impact factor: 3.167

View more
  28 in total

1.  Histologic grade and extent of resection are associated with survival in pediatric spinal cord ependymomas.

Authors:  Michael Safaee; Michael C Oh; Joseph M Kim; Derick Aranda; Phiroz E Tarapore; Tene A Cage; Nalin Gupta; Andrew T Parsa
Journal:  Childs Nerv Syst       Date:  2013-05-16       Impact factor: 1.475

2.  Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients.

Authors:  Elizabeth Vera-Bolanos; Kenneth Aldape; Ying Yuan; Jimin Wu; Khalida Wani; Mary Jo Necesito-Reyes; Howard Colman; Girish Dhall; Frank S Lieberman; Philippe Metellus; Tom Mikkelsen; Antonio Omuro; Sonia Partap; Michael Prados; H Ian Robins; Riccardo Soffietti; Jing Wu; Mark R Gilbert; Terri S Armstrong
Journal:  Neuro Oncol       Date:  2014-08-13       Impact factor: 12.300

3.  Epidermal growth factor receptor overexpression is common and not correlated to gene copy number in ependymoma.

Authors:  Carsten Friedrich; André O von Bueren; Larissa Kolevatova; Christian Bernreuther; Tobias Grob; Diego Sepulveda-Falla; Leander van den Boom; Manfred Westphal; Ronald Simon; Markus Glatzel
Journal:  Childs Nerv Syst       Date:  2015-12-21       Impact factor: 1.475

Review 4.  Central nervous system ependymoma: clinical implications of the new molecular classification, treatment guidelines and controversial issues.

Authors:  P D Delgado-López; E M Corrales-García; E Alonso-García; R García-Leal; R González-Rodrigálvarez; E Araus-Galdós; J Martín-Alonso
Journal:  Clin Transl Oncol       Date:  2019-03-13       Impact factor: 3.405

5.  The use of 5-aminolevulinic acid fluorescence guidance in resection of pediatric brain tumors.

Authors:  M Preuß; C Renner; W Krupp; H Christiansen; L Fischer; A Merkenschlager; W Kieß; W Müller; N Manzo; J Meixensberger; U Nestler
Journal:  Childs Nerv Syst       Date:  2013-05-25       Impact factor: 1.475

6.  Clinical characteristics and surgical outcomes of ependymomas in the upper cervical spinal cord: a single-center experience of 155 consecutive patients.

Authors:  Xiaobin Fei; Wenqing Jia; Heng Gao; Chenlong Yang; Da Li; Zenghui Qian; Bo Han; Dejiang Wang; Yulun Xu
Journal:  Neurosurg Rev       Date:  2020-08-07       Impact factor: 3.042

Review 7.  Biology and management of ependymomas.

Authors:  Jing Wu; Terri S Armstrong; Mark R Gilbert
Journal:  Neuro Oncol       Date:  2016-03-28       Impact factor: 12.300

Review 8.  Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies.

Authors:  Sebastian Zahnreich; Heinz Schmidberger
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

Review 9.  EANO guidelines for the diagnosis and treatment of ependymal tumors.

Authors:  Roberta Rudà; Guido Reifenberger; Didier Frappaz; Stefan M Pfister; Anne Laprie; Thomas Santarius; Patrick Roth; Joerg Christian Tonn; Riccardo Soffietti; Michael Weller; Elizabeth Cohen-Jonathan Moyal
Journal:  Neuro Oncol       Date:  2018-03-27       Impact factor: 12.300

10.  The effect of adjuvant radiotherapy on overall survival in adults with intracranial ependymoma.

Authors:  Roshan S Prabhu; Christopher D Corso; Matthew C Ward; John H Heinzerling; Reshika Dhakal; Zachary S Buchwald; Kirtesh R Patel; Anthony L Asher; Ashley L Sumrall; Stuart H Burri
Journal:  Neurooncol Pract       Date:  2019-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.